Berkeley, CA, United States of America

Isabelle Guyon

USPTO Granted Patents = 25 


 

Average Co-Inventor Count = 2.1

ph-index = 16

Forward Citations = 1,024(Granted Patents)


Company Filing History:


Years Active: 1997-2021

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: Isabelle Guyon: A Pioneer in Cancer Prediction and Machine Learning

Introduction

Isabelle Guyon, based in Berkeley, CA, is a renowned inventor with an impressive portfolio of 25 patents. Her work primarily focuses on innovative methods for screening, predicting, and monitoring prostate cancer, showcasing her commitment to advancing medical research and technology.

Latest Patents

Among her latest contributions, one notable patent outlines a method for screening and predicting prostate cancer by measuring the expression levels of a combination of at least seven genes in patient samples. These samples can be sourced from prostate tissue, blood, semen, or urine, and a prediction score is generated based on the relative expression levels of these genes. This innovative approach aims to separate prostate cancer cases from normal instances effectively.

Another significant patent involves a recursive feature elimination method utilizing support vector machines. This technique identifies a crucial subset of features from a larger group, training a support vector machine with labeled training samples to assess and eliminate less significant features iteratively. The process continues until a manageable number of features remain, capable of accurately classifying the data into distinct categories.

Career Highlights

Isabelle has worked with various companies, including Health Discovery Corporation and Biowulf Technologies, LLC. Her expertise in machine learning and cancer research has established her as a prominent figure in her field. Her innovative patents reflect her dedication to enhancing the detection and treatment of prostate cancer, providing valuable tools for both clinicians and researchers.

Collaborations

Isabelle has collaborated with esteemed colleagues, such as Jason Edward Weston and Stephen D Barnhill. These partnerships have allowed her to expand her work and influence in the realms of medical research and technology, furthering her contributions to cancer prediction and analysis.

Conclusion

Isabelle Guyon's groundbreaking work in the areas of cancer prediction and machine learning has not only resulted in numerous patents but has also significantly impacted the medical community. Her innovative approaches and collaborations highlight her contributions to research and development, marking her as a leading inventor in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…